OTC

Adults aged 65 years and older are the largest group of consumers of OTC medications.

The first nonprescription, OTC naloxone nasal spray (Narcan) was approved by the FDA in March 2023.

These OTC products are recommended to address a variety of symptoms associated with women's health issues.

Dexcom's Stelo will be available in summer 2024.

Reese Pharmaceutical’s ColoTest has a suggested retail price of $19.99 and will also be sold on major retail shelves later this spring.

These OTC products are recommended to address a variety of symptoms that occur during cold and flu seasons.

The nonprofit pharmaceutical company plans to begin fulfilling orders for RiVive more broadly in early 2023 and will make it available across the US for free of charge or at a low breakeven cost.

The test is also the first OTC rapid antigen test cleared for any infectious disease.

Although there were some differences in response after dosing, both OTC and oral prescriptions demonstrated statistically significant improvements in pain.

The approval of norgestrel (Opill) is expected to help reduce barriers to access by allowing people to obtain the medication without needing to see a health care provider.